Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 8953 to 8963 of 8963 entries
Sorted by: Best Match Show Resources per page
Recent Developments in Microbe-Plant-Based Bioremediation for Tackling Heavy Metal-Polluted Soils.

Frontiers in microbiology

Saha L, Tiwari J, Bauddh K, Ma Y.
PMID: 35002995
Front Microbiol. 2021 Dec 23;12:731723. doi: 10.3389/fmicb.2021.731723. eCollection 2021.

Soil contamination with heavy metals (HMs) is a serious concern for the developing world due to its non-biodegradability and significant potential to damage the ecosystem and associated services. Rapid industrialization and activities such as mining, manufacturing, and construction are...

Cite
Saha L, Tiwari J, Bauddh K, et al. Recent Developments in Microbe-Plant-Based Bioremediation for Tackling Heavy Metal-Polluted Soils. Front Microbiol. 2021;12:731723doi: 10.3389/fmicb.2021.731723.
Saha, L., Tiwari, J., Bauddh, K., & Ma, Y. (2021). Recent Developments in Microbe-Plant-Based Bioremediation for Tackling Heavy Metal-Polluted Soils. Frontiers in microbiology, 12731723. https://doi.org/10.3389/fmicb.2021.731723
Saha, Lala, et al. "Recent Developments in Microbe-Plant-Based Bioremediation for Tackling Heavy Metal-Polluted Soils." Frontiers in microbiology vol. 12 (2021): 731723. doi: https://doi.org/10.3389/fmicb.2021.731723
Saha L, Tiwari J, Bauddh K, Ma Y. Recent Developments in Microbe-Plant-Based Bioremediation for Tackling Heavy Metal-Polluted Soils. Front Microbiol. 2021 Dec 23;12:731723. doi: 10.3389/fmicb.2021.731723. eCollection 2021. PMID: 35002995; PMCID: PMC8733405.
Copy Download .nbib Format: NLM
Efficacy and safety of pulsed dye laser for the treatment of surgical scars: a systematic review and meta-analysis.

Lasers in medical science

Cai Y, Zeng X, Ying J, Zhu Y, Qiu Y, Xiang W.
PMID: 34351564
Lasers Med Sci. 2021 Aug 05; doi: 10.1007/s10103-021-03385-z. Epub 2021 Aug 05.

Various clinical trials have explored whether the pulsed dye laser (PDL) method is safe to treat scars, especially surgical scars. However, comprehensive evidence confirming the exact outcomes of PDL for treating surgical scars is lacking. The efficacy and safety...

Cite
Cai Y, Zeng X, Ying J, et al. Efficacy and safety of pulsed dye laser for the treatment of surgical scars: a systematic review and meta-analysis. Lasers Med Sci. 2021;doi: 10.1007/s10103-021-03385-z.
Cai, Y., Zeng, X., Ying, J., Zhu, Y., Qiu, Y., & Xiang, W. (2021). Efficacy and safety of pulsed dye laser for the treatment of surgical scars: a systematic review and meta-analysis. Lasers in medical science, . https://doi.org/10.1007/s10103-021-03385-z
Cai, Yujia, et al. "Efficacy and safety of pulsed dye laser for the treatment of surgical scars: a systematic review and meta-analysis." Lasers in medical science vol. (2021). doi: https://doi.org/10.1007/s10103-021-03385-z
Cai Y, Zeng X, Ying J, Zhu Y, Qiu Y, Xiang W. Efficacy and safety of pulsed dye laser for the treatment of surgical scars: a systematic review and meta-analysis. Lasers Med Sci. 2021 Aug 05; doi: 10.1007/s10103-021-03385-z. Epub 2021 Aug 05. PMID: 34351564.
Copy Download .nbib Format: NLM
A manualised weight management programme for adults with mild-moderate intellectual disabilities affected by excess weight: A randomised controlled feasibility trial (Shape Up-LD).

Journal of applied research in intellectual disabilities : JARID

Lally P, Beeken RJ, Wilson R, Omar R, Hunter R, Fovargue S, Anderson D, King M, Hassiotis A, Croker H.
PMID: 34297441
J Appl Res Intellect Disabil. 2021 Jul 23; doi: 10.1111/jar.12922. Epub 2021 Jul 23.

BACKGROUND: The aim was to pilot an adapted manualised weight management programme for persons with mild-moderate intellectual disabilities affected by overweight or obesity ('Shape Up-LD').METHOD: Adults with intellectual disabilities were enrolled in a 6-month trial (3-month active intervention and...

Cite
Lally P, Beeken RJ, Wilson R, et al. A manualised weight management programme for adults with mild-moderate intellectual disabilities affected by excess weight: A randomised controlled feasibility trial (Shape Up-LD). J Appl Res Intellect Disabil. 2021;doi: 10.1111/jar.12922.
Lally, P., Beeken, R. J., Wilson, R., Omar, R., Hunter, R., Fovargue, S., Anderson, D., King, M., Hassiotis, A., & Croker, H. (2021). A manualised weight management programme for adults with mild-moderate intellectual disabilities affected by excess weight: A randomised controlled feasibility trial (Shape Up-LD). Journal of applied research in intellectual disabilities : JARID, . https://doi.org/10.1111/jar.12922
Lally, Phillippa, et al. "A manualised weight management programme for adults with mild-moderate intellectual disabilities affected by excess weight: A randomised controlled feasibility trial (Shape Up-LD)." Journal of applied research in intellectual disabilities : JARID vol. (2021). doi: https://doi.org/10.1111/jar.12922
Lally P, Beeken RJ, Wilson R, Omar R, Hunter R, Fovargue S, Anderson D, King M, Hassiotis A, Croker H. A manualised weight management programme for adults with mild-moderate intellectual disabilities affected by excess weight: A randomised controlled feasibility trial (Shape Up-LD). J Appl Res Intellect Disabil. 2021 Jul 23; doi: 10.1111/jar.12922. Epub 2021 Jul 23. PMID: 34297441.
Copy Download .nbib Format: NLM
Concurrent Disruption of the Ras/MAPK and NF-κB Pathways Induces Circadian Deregulation and Hepatocarcinogenesis.

Molecular cancer research : MCR

Hanley KL, Liang Y, Wang G, Lin X, Yang M, Karin M, Fu W, Feng GS.
PMID: 34810213
Mol Cancer Res. 2021 Nov 22; doi: 10.1158/1541-7786.MCR-21-0479. Epub 2021 Nov 22.

The Ras/Erk and NF-κB pathways play critical roles in cell proliferation and are known to drive oncogenesis when overactivated. Herein we report a gatekeeper function of the two pathways by working in synergy to suppress liver tumorigenesis. Hepatocyte-specific deletion...

Cite
Hanley KL, Liang Y, Wang G, et al. Concurrent Disruption of the Ras/MAPK and NF-κB Pathways Induces Circadian Deregulation and Hepatocarcinogenesis. Mol Cancer Res. 2021;doi: 10.1158/1541-7786.MCR-21-0479.
Hanley, K. L., Liang, Y., Wang, G., Lin, X., Yang, M., Karin, M., Fu, W., & Feng, G. S. (2021). Concurrent Disruption of the Ras/MAPK and NF-κB Pathways Induces Circadian Deregulation and Hepatocarcinogenesis. Molecular cancer research : MCR, . https://doi.org/10.1158/1541-7786.MCR-21-0479
Hanley, Kaisa L, et al. "Concurrent Disruption of the Ras/MAPK and NF-κB Pathways Induces Circadian Deregulation and Hepatocarcinogenesis." Molecular cancer research : MCR vol. (2021). doi: https://doi.org/10.1158/1541-7786.MCR-21-0479
Hanley KL, Liang Y, Wang G, Lin X, Yang M, Karin M, Fu W, Feng GS. Concurrent Disruption of the Ras/MAPK and NF-κB Pathways Induces Circadian Deregulation and Hepatocarcinogenesis. Mol Cancer Res. 2021 Nov 22; doi: 10.1158/1541-7786.MCR-21-0479. Epub 2021 Nov 22. PMID: 34810213.
Copy Download .nbib Format: NLM
Novel genetic characteristics in low-grade fetal adenocarcinoma of the lung.

Thoracic cancer

Zhang S, Yin H, Zhang J, Yang L, Yang G, Jia J, Jiao Y, Ying J, Wang Y.
PMID: 34464028
Thorac Cancer. 2021 Oct;12(20):2789-2795. doi: 10.1111/1759-7714.14126. Epub 2021 Aug 31.

BACKGROUND: Low-grade fetal adenocarcinoma of the lung (L-FLAC) is a rare subtype of lung adenocarcinoma with undetermined histological features and genetic abnormalities. In this study, we attempted to investigate the pathological characteristics and genomic profiles of L-FLAC.METHODS: Among 9839...

Cite
Zhang S, Yin H, Zhang J, et al. Novel genetic characteristics in low-grade fetal adenocarcinoma of the lung. Thorac Cancer. 2021;12(20):2789-2795doi: 10.1111/1759-7714.14126.
Zhang, S., Yin, H., Zhang, J., Yang, L., Yang, G., Jia, J., Jiao, Y., Ying, J., & Wang, Y. (2021). Novel genetic characteristics in low-grade fetal adenocarcinoma of the lung. Thoracic cancer, 12(20), 2789-2795. https://doi.org/10.1111/1759-7714.14126
Zhang, Shuyang, et al. "Novel genetic characteristics in low-grade fetal adenocarcinoma of the lung." Thoracic cancer vol. 12,20 (2021): 2789-2795. doi: https://doi.org/10.1111/1759-7714.14126
Zhang S, Yin H, Zhang J, Yang L, Yang G, Jia J, Jiao Y, Ying J, Wang Y. Novel genetic characteristics in low-grade fetal adenocarcinoma of the lung. Thorac Cancer. 2021 Oct;12(20):2789-2795. doi: 10.1111/1759-7714.14126. Epub 2021 Aug 31. PMID: 34464028; PMCID: PMC8520817.
Copy Download .nbib Format: NLM
Effect of pH on the Catalytic Degradation of Rhodamine B by Synthesized CDs/g-C.

ACS omega

Guo Y, Zhou C, Fang L, Liu Z, Li W, Yang M.
PMID: 33817471
ACS Omega. 2021 Mar 15;6(12):8119-8130. doi: 10.1021/acsomega.0c05915. eCollection 2021 Mar 30.

The narrow pH range of Fenton oxidation restricts its applicability in water pollution treatment. In this work, a CDs/g-C

Cite
Guo Y, Zhou C, Fang L, et al. Effect of pH on the Catalytic Degradation of Rhodamine B by Synthesized CDs/g-C. ACS Omega. 2021;6(12):8119-8130doi: 10.1021/acsomega.0c05915.
Guo, Y., Zhou, C., Fang, L., Liu, Z., Li, W., & Yang, M. (2021). Effect of pH on the Catalytic Degradation of Rhodamine B by Synthesized CDs/g-C. ACS omega, 6(12), 8119-8130. https://doi.org/10.1021/acsomega.0c05915
Guo, Yulian, et al. "Effect of pH on the Catalytic Degradation of Rhodamine B by Synthesized CDs/g-C." ACS omega vol. 6,12 (2021): 8119-8130. doi: https://doi.org/10.1021/acsomega.0c05915
Guo Y, Zhou C, Fang L, Liu Z, Li W, Yang M. Effect of pH on the Catalytic Degradation of Rhodamine B by Synthesized CDs/g-C. ACS Omega. 2021 Mar 15;6(12):8119-8130. doi: 10.1021/acsomega.0c05915. eCollection 2021 Mar 30. PMID: 33817471; PMCID: PMC8014920.
Copy Download .nbib Format: NLM
Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells.

Molecular neurodegeneration

Li Q, Feng Y, Xue Y, Zhan X, Fu Y, Gui G, Zhou W, Richard JP, Taga A, Li P, Mao X, Maragakis NJ, Ying M.
PMID: 35012575
Mol Neurodegener. 2022 Jan 10;17(1):8. doi: 10.1186/s13024-021-00510-y.

BACKGROUND: Spinal cord motor neurons (MNs) from human iPS cells (iPSCs) have wide applications in disease modeling and therapeutic development for amyotrophic lateral sclerosis (ALS) and other MN-associated neurodegenerative diseases. We need highly efficient MN differentiation strategies for generating...

Cite
Li Q, Feng Y, Xue Y, et al. Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells. Mol Neurodegener. 2022;17(1):8doi: 10.1186/s13024-021-00510-y.
Li, Q., Feng, Y., Xue, Y., Zhan, X., Fu, Y., Gui, G., Zhou, W., Richard, J. P., Taga, A., Li, P., Mao, X., Maragakis, N. J., & Ying, M. (2022). Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells. Molecular neurodegeneration, 17(1), 8. https://doi.org/10.1186/s13024-021-00510-y
Li, Qian, et al. "Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells." Molecular neurodegeneration vol. 17,1 (2022): 8. doi: https://doi.org/10.1186/s13024-021-00510-y
Li Q, Feng Y, Xue Y, Zhan X, Fu Y, Gui G, Zhou W, Richard JP, Taga A, Li P, Mao X, Maragakis NJ, Ying M. Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells. Mol Neurodegener. 2022 Jan 10;17(1):8. doi: 10.1186/s13024-021-00510-y. PMID: 35012575; PMCID: PMC8751314.
Copy Download .nbib Format: NLM
Coordination of m.

Rice (New York, N.Y.)

Cheng Q, Wang P, Wu G, Wang Y, Tan J, Li C, Zhang X, Liu S, Huang S, Huang T, Yang M, He H, Bian J.
PMID: 34224034
Rice (N Y). 2021 Jul 05;14(1):62. doi: 10.1186/s12284-021-00502-y.

N

Cite
Cheng Q, Wang P, Wu G, et al. Coordination of m. Rice (N Y). 2021;14(1):62doi: 10.1186/s12284-021-00502-y.
Cheng, Q., Wang, P., Wu, G., Wang, Y., Tan, J., Li, C., Zhang, X., Liu, S., Huang, S., Huang, T., Yang, M., He, H., & Bian, J. (2021). Coordination of m. Rice (New York, N.Y.), 14(1), 62. https://doi.org/10.1186/s12284-021-00502-y
Cheng, Qin, et al. "Coordination of m." Rice (New York, N.Y.) vol. 14,1 (2021): 62. doi: https://doi.org/10.1186/s12284-021-00502-y
Cheng Q, Wang P, Wu G, Wang Y, Tan J, Li C, Zhang X, Liu S, Huang S, Huang T, Yang M, He H, Bian J. Coordination of m. Rice (N Y). 2021 Jul 05;14(1):62. doi: 10.1186/s12284-021-00502-y. PMID: 34224034; PMCID: PMC8257850.
Copy Download .nbib Format: NLM
Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice.

Molecular therapy. Methods & clinical development

Freyn AW, Pine M, Rosado VC, Benz M, Muramatsu H, Beattie M, Tam YK, Krammer F, Palese P, Nachbagauer R, McMahon M, Pardi N.
PMID: 34485597
Mol Ther Methods Clin Dev. 2021 Jun 12;22:84-95. doi: 10.1016/j.omtm.2021.06.003. eCollection 2021 Sep 10.

Nucleoside-modified, lipid nanoparticle-encapsulated mRNAs have recently emerged as suitable vaccines for influenza viruses and other pathogens in part because the platform allows delivery of multiple antigens in a single immunization. mRNA vaccines allow for easy antigen modification, enabling rapid...

Cite
Freyn AW, Pine M, Rosado VC, et al. Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice. Mol Ther Methods Clin Dev. 2021;22:84-95doi: 10.1016/j.omtm.2021.06.003.
Freyn, A. W., Pine, M., Rosado, V. C., Benz, M., Muramatsu, H., Beattie, M., Tam, Y. K., Krammer, F., Palese, P., Nachbagauer, R., McMahon, M., & Pardi, N. (2021). Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice. Molecular therapy. Methods & clinical development, 2284-95. https://doi.org/10.1016/j.omtm.2021.06.003
Freyn, Alec W, et al. "Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice." Molecular therapy. Methods & clinical development vol. 22 (2021): 84-95. doi: https://doi.org/10.1016/j.omtm.2021.06.003
Freyn AW, Pine M, Rosado VC, Benz M, Muramatsu H, Beattie M, Tam YK, Krammer F, Palese P, Nachbagauer R, McMahon M, Pardi N. Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice. Mol Ther Methods Clin Dev. 2021 Jun 12;22:84-95. doi: 10.1016/j.omtm.2021.06.003. eCollection 2021 Sep 10. PMID: 34485597; PMCID: PMC8390451.
Copy Download .nbib Format: NLM
Macrophage membrane- and cRGD-functionalized thermosensitive liposomes combined with CPP to realize precise siRNA delivery into tumor cells.

Molecular therapy. Nucleic acids

Nai J, Zhang J, Li J, Li H, Yang Y, Yang M, Wang Y, Gong W, Li Z, Li L, Gao C.
PMID: 35024246
Mol Ther Nucleic Acids. 2021 Dec 11;27:349-362. doi: 10.1016/j.omtn.2021.12.016. eCollection 2022 Mar 08.

Despite the success of small interfering RNAs (siRNAs) in clinical settings, their fast clearance and poor delivery efficiency to target cells still hinder their therapeutic effect. Herein, a new treatment system was constructed by combining thermosensitive liposomes with the...

Cite
Nai J, Zhang J, Li J, et al. Macrophage membrane- and cRGD-functionalized thermosensitive liposomes combined with CPP to realize precise siRNA delivery into tumor cells. Mol Ther Nucleic Acids. 2021;27:349-362doi: 10.1016/j.omtn.2021.12.016.
Nai, J., Zhang, J., Li, J., Li, H., Yang, Y., Yang, M., Wang, Y., Gong, W., Li, Z., Li, L., & Gao, C. (2022). Macrophage membrane- and cRGD-functionalized thermosensitive liposomes combined with CPP to realize precise siRNA delivery into tumor cells. Molecular therapy. Nucleic acids, 27349-362. https://doi.org/10.1016/j.omtn.2021.12.016
Nai, Jingxue, et al. "Macrophage membrane- and cRGD-functionalized thermosensitive liposomes combined with CPP to realize precise siRNA delivery into tumor cells." Molecular therapy. Nucleic acids vol. 27 (2022): 349-362. doi: https://doi.org/10.1016/j.omtn.2021.12.016
Nai J, Zhang J, Li J, Li H, Yang Y, Yang M, Wang Y, Gong W, Li Z, Li L, Gao C. Macrophage membrane- and cRGD-functionalized thermosensitive liposomes combined with CPP to realize precise siRNA delivery into tumor cells. Mol Ther Nucleic Acids. 2021 Dec 11;27:349-362. doi: 10.1016/j.omtn.2021.12.016. eCollection 2022 Mar 08. PMID: 35024246; PMCID: PMC8724933.
Copy Download .nbib Format: NLM
Identification of a novel EXT2 frameshift mutation in a family with hereditary multiple exostoses by whole-exome sequencing.

Journal of clinical laboratory analysis

Yang M, Xie H, Xu B, Xiang Q, Wang H, Hu T, Liu S.
PMID: 34403521
J Clin Lab Anal. 2021 Sep;35(9):e23968. doi: 10.1002/jcla.23968. Epub 2021 Aug 17.

BACKGROUND: Hereditary multiple exostoses (HME), also referred to as multiple osteochondromas, is an autosomal dominant skeletal disease characterized by the development of multiple overgrown benign bony tumors capped by cartilage and is associated with bone deformity, joint limitation, and...

Cite
Yang M, Xie H, Xu B, et al. Identification of a novel EXT2 frameshift mutation in a family with hereditary multiple exostoses by whole-exome sequencing. J Clin Lab Anal. 2021;35(9):e23968doi: 10.1002/jcla.23968.
Yang, M., Xie, H., Xu, B., Xiang, Q., Wang, H., Hu, T., & Liu, S. (2021). Identification of a novel EXT2 frameshift mutation in a family with hereditary multiple exostoses by whole-exome sequencing. Journal of clinical laboratory analysis, 35(9), e23968. https://doi.org/10.1002/jcla.23968
Yang, Mei, et al. "Identification of a novel EXT2 frameshift mutation in a family with hereditary multiple exostoses by whole-exome sequencing." Journal of clinical laboratory analysis vol. 35,9 (2021): e23968. doi: https://doi.org/10.1002/jcla.23968
Yang M, Xie H, Xu B, Xiang Q, Wang H, Hu T, Liu S. Identification of a novel EXT2 frameshift mutation in a family with hereditary multiple exostoses by whole-exome sequencing. J Clin Lab Anal. 2021 Sep;35(9):e23968. doi: 10.1002/jcla.23968. Epub 2021 Aug 17. PMID: 34403521; PMCID: PMC8418499.
Copy Download .nbib Format: NLM
Showing 8953 to 8963 of 8963 entries